Revolution Medicines, Inc.
RVMD
$99.00
$4.144.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.56% | -23.17% | -16.11% | -9.69% | -24.49% |
| Total Depreciation and Amortization | 13.97% | 12.10% | 5.44% | 10.66% | 19.79% |
| Total Amortization of Deferred Charges | -66.67% | 50.00% | -33.33% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 44.71% | 39.89% | 106.82% | 17.99% | -14.08% |
| Change in Net Operating Assets | -42.87% | 1,411.71% | -276.57% | -94.20% | 306.42% |
| Cash from Operations | -32.28% | 6.51% | -14.05% | -40.60% | -6.04% |
| Capital Expenditure | 42.52% | 55.05% | -128.11% | -167.27% | 65.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 172.38% | -32.42% | 428.99% | 96.76% | -2,082.19% |
| Cash from Investing | 201.35% | -27.50% | 314.91% | 95.94% | -1,730.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,710.70% | -36.97% | 637.78% | -99.89% | 906.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 103.33% | -102.30% | 1,389,000.00% | -100.02% | -- |
| Cash from Financing | 23,068.53% | -100.62% | 29,257.32% | -99.90% | 1,030.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 190.36% | -366.35% | 132.98% | -161.15% | 559.30% |